Overview:
SeraCare’s comprehensive suite of patient-like reference materials accelerates development, streamlines validation, and ensures confidence in the results of today’s demanding clinical genomics assays. Our platform-agnostic, ground-truth reference materials can be used through all development phases to verify actionable and challenging variants as well as complex genomic signatures in patient samples.
Features:
- Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs, and RNA fusions
- Highly multiplexed - provides significantly more data per NGS run, saving sequencing costs
- Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA in plasma, and FFPE
- Manufactured in cGMP-compliant, ISO 13485-certified facilities
- Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers
- Compatible Workflows: NGS, Sanger Sequencing, Real Time PCR, Digital PCR (dPCR) and Microarray.
- Somatic cancer - solid tumor, heme malignancy, immuno-oncology, and liquid biopsy
- Reproductive health - NIPT (trisomies, microdeletions, sex chromosome aneuploidies)
- Inherited cancer and cardiomyopathy
- Infectious disease - HIV and SARS-CoV-2
